In part 3 of this Exclusive Interview, Catherine Champagne talks with Diabetes in Control Publisher Steve Freed about her findings regarding fad diets.
Read More »Catherine Champagne Part 4, What Is Your Recommended Diet?
In part 4 of this Exclusive Interview, Catherine Champagne talks with Diabetes in Control Publisher Steve Freed about her methods for implementing dietary changes.
Read More »Catherine Champagne Part 5, Takeaway Message From Fad Diet Presentation
In part 5 of this Exclusive Interview, Catherine Champagne talks with Diabetes in Control Publisher Steve Freed about findings regarding coconut oil and low calorie sweeteners.
Read More »Catherine Champagne Part 6, Low Calorie Sweeteners
In part 6 of this Exclusive Interview, Catherine Champagne talks with Diabetes in Control Publisher Steve Freed about the use of artificial and low calorie sweeteners.
Read More »Catherine Champagne Part 7, Fad Drinks And Drink Substitutes
In part 7, the conclusion of this Exclusive Interview, Catherine Champagne talks with Diabetes in Control Publisher Steve Freed about the science behind some popular drinks.
Read More »Prediabetes And Risk of Developing Cardiovascular Disease
Study looks at possible increase in heart disease among people diagnosed with diabetes after middle age.
Read More »Effects of Resistance Training On Insulin Sensitivity
Short duration, high intensity resistance exercise to increase muscle strength and mass shown beneficial.
Read More »Cannabis-Based Medicine
A recent Cochrane Review found which one of the following to be true about the effects of cannabis-based medicines on neuropathic pain?
A. All cannabis-based medicines (herbal, plant-derived, synthetic) pooled together were more effective than placebo for pain relief.
B. Herbal cannabis medicines were more effective than placebo for pain relief.
C. There was a high level of evidence that cannabis-based medicines were more effective than placebo for pain relief.
D. All of the above are true.
E. None of the above is true.
Follow the link for the answer.
Read More »Samples Are Not the Answer
A woman, 72 years of age was recently diagnosed with type 2 diabetes. She has a Medicare plan. I don’t know her financial situation but do know she gets Social Security and has other retirement income. Her A1C was rising. We had recommended and taught lifestyle changes which she had difficulty with; she made some changes but not enough to lower her glucose. We added metformin which she did not tolerate, so we discussed one of the SGLT-2s. After hesitating, she agreed to trying one. We gave her samples, she took them. Her A1C lowered to the goal we mutually decided upon.
Read More »Diabetes Apps Presentation Part 4
In this week's Homerun Slides, mobile diabetes apps as an effective method to provide diabetes education and coaching.
Read More »